Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 August 2020 | Story Loenie Bolleurs | Photo Charl Devenish
Saajida Abdulla believes great leaders are ambitious, driven, and aspire for transformation, but never purely for themselves. They are ambitious for others and possess an indefinite will to do whatever is necessary in service of this greater cause.

Coming from a strong business and entrepreneurial background, Saajida Abdulla is currently serving her Industrial Psychology internship in the Department of Organisational Development and Employee Wellness at the University of the Free State (UFS). 

Abdulla’s academic background includes several degrees in both psychology and business. After completing an honours degree in Business Sciences, she worked in the retail sector for several years. 

However, she still felt unfulfilled in her career path and returned to the world of academia to combine her passion for psychology and her inherent business strengths by pursuing further studies in Industrial Psychology. 

An interview with Abdulla sheds light on some of her dreams, inspirations, and challenges. 

Is there a woman who inspires you and who you would like to celebrate this Women’s Month, and why?

I am inspired by STRONG WOMEN LEADERS, those who are accelerants for change, who have pushed through obstacles, challenged the status quo, and strived for transformation in their space – woman branded with tenacity, grit, resilience, and the vision to lead others to excellence.

My greatest inspiration is my mother. Her strength of character, resilience, and perseverance in overcoming adversity is what inspires me to keep going and be the best I can be. 

I am inspired by STRONG WOMEN LEADERS, those who are accelerants for change, who have pushed through obstacles, challenged the status quo, and strived for transformation in their space. - Saajida Abdulla

What are some challenges you have faced in your life that have made you a better woman?

If I had to single out some of the challenges I have faced, I would say failure. The taste of failure and disappointment has propelled me to keep pushing myself and to not allow situations to define me. I have learnt to view failure as nothing but a temporary setback, because if you allow the feelings of failure and disappointment to halt your growth, you will never evolve. 

What advice would you give to the 15-year-old you?

Your life has been designed by the best of architects, and even though you may not understand all the turns and detours, they are all absolutely necessary to take you to the exact places you need to be. On this journey, you will also encounter setbacks and failure, but embrace it, for it will lead to the evolution of your success. 

What would you say makes you a champion woman [of the UFS]?

I am honoured to be considered as one of the UFS’s champion women, and I believe it is inherently linked to my strive for great leadership. I critically evaluate and challenge situations, provide a vision for innovative problem solving, and direct change and transformation within all areas of my personal and professional life. However, the greatest quality that makes me a champion woman of the UFS, is my fundamental purpose to make a difference in the lives of others.

 


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept